These findings suggest that high RRM2 expression is primarily responsible for carcinogenesis in the majority of tumor types, adding fresh insight to the primary pathogenesis of various tumors and providing an innovative clinical biomarker that can predict the overall survival of cancer patients. The gene discussed is RRM2; the disease is neoplasm.